07/05/2026
In May 2024, a rescue dog named Rosie was given months to live. Her owner was told there was nothing more to be done.
He didn't accept that.
Paul Conyngham had no biology background, no lab, no institution behind him. Just a data engineer's instincts and a love for one dog. Over the next year he taught himself computational genomics from scratch, sequenced Rosie's DNA, and designed something nobody had ever built before: a personalized mRNA cancer vaccine for a dog. 🐶🔬
It worked. Six weeks after her first injection the tumors were shrinking. By January she was jumping fences at the dog park chasing rabbits.
But what stayed with us was not the breakthrough. It was the cost of getting there. The months lost to dead ends, the patent wall he hit after two weeks of computation, the right collaborators found only by chance after months of cold emails. There are more people like Paul out there. People with real problems, real capability, and no clear map. To us, that's a problem worth solving. 💡
Read the full story: https://bit.ly/4uvnqPq
Paul Conyngham had no background in biology. He had a dying rescue dog, a data engineer's instincts, and a year he refused to waste. What followed was the first personalized mRNA cancer vaccine ever designed for a dog, built by someone who had never studied biology in his life. We broke down what hi...
